-+ 0.00%
-+ 0.00%
-+ 0.00%

Grifols wins FDA approval for Procleix Plasmodium malaria blood screening assay

PUBT·04/16/2026 12:22:28
Listen to the news
Grifols wins FDA approval for Procleix Plasmodium malaria blood screening assay
  • Grifols secured FDA clearance for Procleix Plasmodium Assay to screen US blood donors for malaria.
  • Test runs on Procleix Panther System, expanding Grifols Procleix blood screening portfolio.
  • Grifols expects assay to cut transfusion-transmitted malaria risk, easing donor deferrals tied to malaria exposure.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grifols SA published the original content used to generate this news brief on April 16, 2026, and is solely responsible for the information contained therein.